1. Del Fabbro M, Corbella S, Weinstein T, Ceresoli V, Taschieri S. Implant survival rates after osteotome-mediated maxillary sinus augmentation: a systematic review. Clin Implant Dent Relat Res. 2012; 14:Suppl 1. e159–68.
![crossref](/image/icon/bnr_ref_cross.gif)
2. Browaeys H, Bouvry P, De Bruyn H. A literature review on biomaterials in sinus augmentation procedures. Clin Implant Dent Relat Res. 2007; 9:166–243.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Araújo M, Linder E, Lindhe J. Effect of a xenograft on early bone formation in extraction sockets: an experimental study in dog. Clin Oral Implants Res. 2009; 20:1–6.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Shanbhag S, Shanbhag V, Stavropoulos A. Volume changes of maxillary sinus augmentations over time: a systematic review. Int J Oral Maxillofac Implants. 2014; 29:881–973.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Lee J, Susin C, Rodriguez NA, de Stefano J, Prasad HS, Buxton AN, et al. Sinus augmentation using rhBMP-2/ACS in a mini-pig model: relative efficacy of autogenous fresh particulate iliac bone grafts. Clin Oral Implants Res. 2013; 24:497–504.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Yamada Y, Nakamura S, Ueda M, Ito K. Osteotome technique with injectable tissue-engineered bone and simultaneous implant placement by cell therapy. Clin Oral Implants Res. 2013; 24:468–542.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Lundgren S, Cricchio G, Palma VC, Salata LA, Sennerby L. Sinus membrane elevation and simultaneous insertion of dental implants: a new surgical technique in maxillary sinus floor augmentation. Periodontol 2000. 2008; 47:193–205.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Lundgren S, Andersson S, Gualini F, Sennerby L. Bone reformation with sinus membrane elevation: a new surgical technique for maxillary sinus floor augmentation. Clin Implant Dent Relat Res. 2004; 6:165–238.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Palma VC, Magro-Filho O, de Oliveria JA, Lundgren S, Salata LA, Sennerby L. Bone reformation and implant integration following maxillary sinus membrane elevation: an experimental study in primates. Clin Implant Dent Relat Res. 2006; 8:11–24.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Cricchio G, Sennerby L, Lundgren S. Sinus bone formation and implant survival after sinus membrane elevation and implant placement: a 1- to 6-year follow-up study. Clin Oral Implants Res. 2011; 22:1200–1212.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Ellegaard B, Baelum V, Kølsen-Petersen J. Non-grafted sinus implants in periodontally compromised patients: a time-to-event analysis. Clin Oral Implants Res. 2006; 17:156–220.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Thor A, Sennerby L, Hirsch JM, Rasmusson L. Bone formation at the maxillary sinus floor following simultaneous elevation of the mucosal lining and implant installation without graft material: an evaluation of 20 patients treated with 44 Astra Tech implants. J Oral Maxillofac Surg. 2007; 65:Suppl 1. 64–72.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Cricchio G, Imburgia M, Sennerby L, Lundgren S. Immediate loading of implants placed simultaneously with sinus membrane elevation in the posterior atrophic maxilla: a two-year follow-up study on 10 patients. Clin Implant Dent Relat Res. 2014; 16:609–626.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Pinchasov G, Juodzbalys G. Graft-free sinus augmentation procedure: a literature review. J Oral Maxillofac Res. 2014; 5:e1.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Hatano N, Sennerby L, Lundgren S. Maxillary sinus augmentation using sinus membrane elevation and peripheral venous blood for implant-supported rehabilitation of the atrophic posterior maxilla: case series. Clin Implant Dent Relat Res. 2007; 9:150–155.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Iida S, Tanaka N, Kogo M, Matsuya T. Migration of a dental implant into the maxillary sinus. A case report. Int J Oral Maxillofac Surg. 2000; 29:358–367.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Raghoebar GM, van Weissenbruch R, Vissink A. Rhino-sinusitis related to endosseous implants extending into the nasal cavity. A case report. Int J Oral Maxillofac Surg. 2004; 33:312–316.
18. Cole BJ, Bostrom MP, Pritchard TL, Sumner DR, Tomin E, Lane JM, et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop Relat Res. 1997; (345):219–247.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Schmidmaier G, Wildemann B, Cromme F, Kandziora F, Haas NP, Raschke M. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. Bone. 2002; 30:816–838.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Hall J, Sorensen RG, Wozney JM, Wikesjö UM. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J Clin Periodontol. 2007; 34:444–495.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Wikesjö UM, Qahash M, Polimeni G, Susin C, Shanaman RH, Rohrer MD, et al. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations. J Clin Periodontol. 2008; 35:1001–1011.
![crossref](/image/icon/bnr_ref_cross.gif)
22. Pelaez M, Susin C, Lee J, Fiorini T, Bisch FC, Dixon DR, et al. Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model. J Clin Periodontol. 2014; 41:827–863.
![crossref](/image/icon/bnr_ref_cross.gif)
23. Choi Y, Yun JH, Kim CS, Choi SH, Chai JK, Jung UW. Sinus augmentation using absorbable collagen sponge loaded with Escherichia coli-expressed recombinant human bone morphogenetic protein 2 in a standardized rabbit sinus model: a radiographic and histologic analysis. Clin Oral Implants Res. 2012; 23:682–691.
24. Hong JY, Kim MS, Lim HC, Lee JS, Choi SH, Jung UW. A high concentration of recombinant human bone morphogenetic protein-2 induces low-efficacy bone regeneration in sinus augmentation: a histomorphometric analysis in rabbits. Clin Oral Implants Res. 2015.
![crossref](/image/icon/bnr_ref_cross.gif)
25. Leknes KN, Yang J, Qahash M, Polimeni G, Susin C, Wikesjö UM. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations. Clin Oral Implants Res. 2008; 19:1027–1060.
![crossref](/image/icon/bnr_ref_cross.gif)
26. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25:1468–1554.
![crossref](/image/icon/bnr_ref_cross.gif)
27. Jung UW, Unursaikhan O, Park JY, Lee JS, Otgonbold J, Choi SH. Tenting effect of the elevated sinus membrane over an implant with adjunctive use of a hydroxyapatite-powdered collagen membrane in rabbits. Clin Oral Implants Res. 2015; 26:663–733.
![crossref](/image/icon/bnr_ref_cross.gif)
28. Lee SW, Hahn BD, Kang TY, Lee MJ, Choi JY, Kim MK, et al. Hydroxyapatite and collagen combination-coated dental implants display better bone formation in the peri-implant area than the same combination plus bone morphogenetic protein-2-coated implants, hydroxyapatite only coated implants, and uncoated implants. J Oral Maxillofac Surg. 2014; 72:53–60.
![crossref](/image/icon/bnr_ref_cross.gif)
29. Srouji S, Kizhner T, Ben David D, Riminucci M, Bianco P, Livne E. The Schneiderian membrane contains osteoprogenitor cells: in vivo and in vitro study. Calcif Tissue Int. 2009; 84:138–183.
![crossref](/image/icon/bnr_ref_cross.gif)
30. Gruber R, Kandler B, Fuerst G, Fischer MB, Watzek G. Porcine sinus mucosa holds cells that respond to bone morphogenetic protein (BMP)-6 and BMP-7 with increased osteogenic differentiation in vitro. Clin Oral Implants Res. 2004; 15:575–655.
![crossref](/image/icon/bnr_ref_cross.gif)
31. Choi Y, Lee JS, Kim YJ, Kim MS, Choi SH, Cho KS, et al. Recombinant human bone morphogenetic protein-2 stimulates the osteogenic potential of the Schneiderian membrane: a histometric analysis in rabbits. Tissue Eng Part A. 2013; 19:1994–2004.
![crossref](/image/icon/bnr_ref_cross.gif)
32. Lee J, Decker JF, Polimeni G, Cortella CA, Rohrer MD, Wozney JM, et al. Evaluation of implants coated with rhBMP-2 using two different coating strategies: a critical-size supraalveolar peri-implant defect study in dogs. J Clin Periodontol. 2010; 37:582–672.
![crossref](/image/icon/bnr_ref_cross.gif)
33. Decker JF, Lee J, Cortella CA, Polimeni G, Rohrer MD, Wozney JM, et al. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs. J Periodontol. 2010; 81:1839–1888.
![crossref](/image/icon/bnr_ref_cross.gif)
34. Kim MS, Kwon JY, Lee JS, Song JS, Choi SH, Jung UW. Low-dose recombinant human bone morphogenetic protein-2 to enhance the osteogenic potential of the Schneiderian membrane in the early healing phase: in vitro and in vivo studies. J Oral Maxillofac Surg. 2014; 72:1480–1574.